Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Grace K Dy

1-50 of 100 results

View this query on the Wikidata Query Service
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

scientific article
Small Cell Lung Cancer

scientific article published on 01 March 2008
Understanding, recognizing, and managing toxicities of targeted anticancer therapies

scientific article published on May 28, 2013
BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins

scientific article
Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage

scientific article published on 01 October 2004
Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study

scientific article
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study.

scientific article published on 8 August 2005
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.

scientific article
Farnesyl transferase inhibitors as anticancer agents

scientific article
Complementary and alternative medicine use by patients enrolled onto phase I clinical trials

scientific article published in December 2004
Advances in Cancer Immunotherapy in Solid Tumors

scientific article
Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors

scientific article published on July 13, 2011
Novel targets for lung cancer therapy: part I.

scientific article
A Phase I/II Study of Erlotinib in Combination with the Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody IMC-A12 (Cixutumumab) in Patients with Advanced Non-small Cell Lung Cancer

scientific article published on February 1, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.

scientific article published in May 2012
A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer

scientific article
Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer

scientific article published on February 22, 2013
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

scientific article
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

scientific article
First line treatment of advanced non-small-cell lung cancer – specific focus on albumin bound paclitaxel

scientific article published on December 24, 2013
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528

scientific article
Systemic cancer therapy: evolution over the last 60 years

scientific article published on October 2008
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.

scientific article
A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326.

scientific article published on December 2010
Novel targets for lung cancer therapy: part II.

scientific article
A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

scientific article
A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies

scientific article
Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer

scientific article published on February 14, 2012
Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study.

scientific article published on September 2010
Improved Response to nab-Paclitaxel Compared with Cremophor-Solubilized Paclitaxel is Independent of Secreted Protein Acidic and Rich in Cysteine Expression in Non-Small Cell Lung Cancer

scientific article published on June 1, 2011
Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer

scientific article published on June 1, 2011
A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis

scientific article published on August 2007
A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors

scientific article published on November 5, 2014
A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations

scientific article published on September 2007
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

scientific article published on 05 July 2018
A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer

scientific article published on February 23, 2013
Emerging therapeutic targets in non-small cell lung cancer

scientific article published on April 2009
Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.

scientific article
The Prognostic Significance of Focal Adhesion Kinase Expression in Stage I Non–Small-Cell Lung Cancer

scientific article published on September 1, 2014
Identification and characterization of genetic variation in the folylpolyglutamate synthase gene

scientific article published on 01 September 2007
A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer.

scientific article
Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review

scientific article published on February 1, 2014
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

scholarly article by Jeffrey M Conroy et al published 24 January 2019 in Journal for Immunotherapy of Cancer
P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets): Track: Immunotherapy

scientific article
A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors

scientific article published on 21 September 2016
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced

scientific article
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

scientific article
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

scholarly article by Sarabjot Pabla et al published 1 February 2019 in Journal for Immunotherapy of Cancer
Phase 1b study of the oral gemcitabine ‘Pro-drug’ LY2334737 in combination with capecitabine in patients with advanced solid tumors

scientific article published on February 3, 2015
Angiogenesis inhibitors in lung cancer: a promise fulfilled

scientific article published on May 2006

Paulina is supported by:

About Paulina

Help